Patent AT-E400584-T1: [Translated] NEW LIGAND AND DNA FROM IT
Peptides (I) (of six sequences (GPR7 ligands A through F) of human, mouse, rat and bovine origin, given in the specification) which bind to the GPR7 opioid-somatostatin-like receptor protein, and the amides, esters and salts of these peptides, and their derivatives brominated at the N-terminal amino acid, are new. Independent claims are also included for (1) peptides containing partial sequences of (I); (2) precursor peptides of (I); (3) polynucleotides encoding all or part of (I); (4) expression vectors containing these polynucleotides; (5) hosts transformed by the expression vectors; (6) preparation of (I) or their partial peptides or precursors, by culture of host cells transformed by the expression vectors; (7) antibodies to all or part of (I); (8) drug compositions containing peptides (I), their partial peptides, polynucleotides encoding them, or antibodies recognizing them; (9) diagnostic reagents containing polynucleotides encoding all or part of (I), or antibodies recognizing all or part of (I); (10) screening compounds modifying the binding of (I) to GPR7 or modifying the degree of expression of (I); (11) compounds identified by the screening method; (12) drug compositions containing these compounds; (13) kits for carrying out the screening method; (14) bovine GPR7 receptor protein and its partial peptides; (15) polynucleotides encoding all or part of bovine GPR7; (16) expression vectors containing these polynucleotides; (17) hosts transformed by the expression vectors; (18) preparation of bovine GPR7 and its partial peptides by culture of the transformed host cells; (19) antibodies to bovine GPR7; (20) drug compositions containing bovine GPR7, its partial peptides, polynucleotides encoding it or antibodies recognizing it; (21) diagnostic reagents containing antibodies to bovine GPR7 or polynucleotides encoding all or part of bovine GPR7; (22) bovine GPR8 receptor protein and its partial peptides; (23) polynucleotides encoding all or part of bovine GPR8; expression vectors containing these polynucleotides; (24) hosts transformed by the expression vectors; (25) preparation of bovine GPR8 and its partial peptides by culture of the transformed host cells; (26) antibodies to bovine GPR8; (27) drug compositions containing bovine GPR8, its partial peptides, polynucleotides encoding it or antibodies recognizing it; (28) diagnostic reagents containing antibodies to bovine GPR8 or polynucleotides encoding all or part of bovine GPR8; (29) non-human mammals which are transgenic animals containing foreign DNA encoding (I), bovine GPR7 or bovine GPR8, or are knockout animals for the genes encoding (I), bovine GPR7 or bovine GPR8; (30) non-human mammal embryonic stem cells (ES cells) having the gene for (I), bovine GPR7 or bovine GPR8 in an inactivated form; (31) expression vectors for (I) in mammals; and (32) screening compounds for their ability to modify the promoter activity of the gene for (I), bovine GPR7 or bovine GPR8, using non-human mammals transformed by a reporter gene under the control of the promoter region of the gene for (I), bovine GPR7 or bovine GPR8. ACTIVITY : Anorectic; Cytostatic. No biological data is given. MECHANISM OF ACTION : Modifying the binding of the opioid-somatostatin-like receptor GPR7 to its ligands; (I) and N-terminal brominated derivatives have an agonist effect on GPR7 expression.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH/NCBI Data Team",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@ncbi.nlm.nih.gov"
}
|
| description | Peptides (I) (of six sequences (GPR7 ligands A through F) of human, mouse, rat and bovine origin, given in the specification) which bind to the GPR7 opioid-somatostatin-like receptor protein, and the amides, esters and salts of these peptides, and their derivatives brominated at the N-terminal amino acid, are new. Independent claims are also included for (1) peptides containing partial sequences of (I); (2) precursor peptides of (I); (3) polynucleotides encoding all or part of (I); (4) expression vectors containing these polynucleotides; (5) hosts transformed by the expression vectors; (6) preparation of (I) or their partial peptides or precursors, by culture of host cells transformed by the expression vectors; (7) antibodies to all or part of (I); (8) drug compositions containing peptides (I), their partial peptides, polynucleotides encoding them, or antibodies recognizing them; (9) diagnostic reagents containing polynucleotides encoding all or part of (I), or antibodies recognizing all or part of (I); (10) screening compounds modifying the binding of (I) to GPR7 or modifying the degree of expression of (I); (11) compounds identified by the screening method; (12) drug compositions containing these compounds; (13) kits for carrying out the screening method; (14) bovine GPR7 receptor protein and its partial peptides; (15) polynucleotides encoding all or part of bovine GPR7; (16) expression vectors containing these polynucleotides; (17) hosts transformed by the expression vectors; (18) preparation of bovine GPR7 and its partial peptides by culture of the transformed host cells; (19) antibodies to bovine GPR7; (20) drug compositions containing bovine GPR7, its partial peptides, polynucleotides encoding it or antibodies recognizing it; (21) diagnostic reagents containing antibodies to bovine GPR7 or polynucleotides encoding all or part of bovine GPR7; (22) bovine GPR8 receptor protein and its partial peptides; (23) polynucleotides encoding all or part of bovine GPR8; expression vectors containing these polynucleotides; (24) hosts transformed by the expression vectors; (25) preparation of bovine GPR8 and its partial peptides by culture of the transformed host cells; (26) antibodies to bovine GPR8; (27) drug compositions containing bovine GPR8, its partial peptides, polynucleotides encoding it or antibodies recognizing it; (28) diagnostic reagents containing antibodies to bovine GPR8 or polynucleotides encoding all or part of bovine GPR8; (29) non-human mammals which are transgenic animals containing foreign DNA encoding (I), bovine GPR7 or bovine GPR8, or are knockout animals for the genes encoding (I), bovine GPR7 or bovine GPR8; (30) non-human mammal embryonic stem cells (ES cells) having the gene for (I), bovine GPR7 or bovine GPR8 in an inactivated form; (31) expression vectors for (I) in mammals; and (32) screening compounds for their ability to modify the promoter activity of the gene for (I), bovine GPR7 or bovine GPR8, using non-human mammals transformed by a reporter gene under the control of the promoter region of the gene for (I), bovine GPR7 or bovine GPR8. ACTIVITY : Anorectic; Cytostatic. No biological data is given. MECHANISM OF ACTION : Modifying the binding of the opioid-somatostatin-like receptor GPR7 to its ligands; (I) and N-terminal brominated derivatives have an agonist effect on GPR7 expression. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Data Source",
"mediaType": "text/html",
"description": "Access the complete Patent AT-E400584-T1: [Translated] NEW LIGAND AND DNA FROM IT on the official website.",
"downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400584-T1"
}
]
|
| identifier | https://healthdata.gov/api/views/re53-qunb |
| issued | 2025-09-05 |
| keyword |
[
"chemistry",
"innovation",
"patent",
"pubchem",
"research"
]
|
| landingPage | https://healthdata.gov/d/re53-qunb |
| modified | 2025-09-06 |
| programCode |
[
"009:066"
]
|
| publisher |
{
"name": "National Center for Biotechnology Information (NCBI)",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Patent AT-E400584-T1: [Translated] NEW LIGAND AND DNA FROM IT |